E. Merisko-Liversidge

Pharmaceutical Science · 2003–2011

A researcher in the Science corpus: 3 papers; trusts 6 researchers and is trusted by 10 researchers here, as inferred from the citation graph.

Subfields

• Pharmaceutical Science — 22 citations into it; #26 of 142 by trust here, #50 by citations
• Biomaterials — 16 citations into it; #418 of 2,152 by trust here, #1,180 by citations
• Molecular Biology — 15 citations into it
• Materials Chemistry — 9 citations into it

Whom E. Merisko-Liversidge trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. R. Müller
2. B. Rabinow
3. Colin W. Pouton
4. Christopher A. Lipinski
5. C. Keck
6. J. Breitenbach
7. A. Gabizon

Who trusts E. Merisko-Liversidge overall

1. E. Acosta
2. H. Williams
3. J. Möschwitzer
4. Natalie L. Trevaskis
5. B. Rabinow
6. R. Müller
7. Colin W. Pouton
8. S. Charman
9. R. Shegokar
10. V. R. Patel

Papers from E. Merisko-Liversidge's perspective

Ordered by how strongly the researchers E. Merisko-Liversidge trusts endorse each paper. Same corpus, a different order for every researcher.

1. Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. (Angewandte Chemie)
2. Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
3. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. (European journal of pharmaceutics and biopharmaceutics)
4. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. (Advanced Drug Delivery Reviews)
5. What is the True Solubility Advantage for Amorphous Pharmaceuticals? (Pharmaceutical Research)
6. Solid lipid nanoparticles: production, characterization and applications. (Advanced Drug Delivery Reviews)
7. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. (Journal of Controlled Release)
8. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs (Nature reviews. Drug discovery)
9. Nanosizing: a formulation approach for poorly-water-soluble compounds. (European Journal of Pharmaceutical Sciences)
10. Nanosizing--oral formulation development and biopharmaceutical evaluation. (Advanced Drug Delivery Reviews)

Their papers

• Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology. (2011) — 606 citations
• Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds (2008) — 594 citations
• Nanosizing: a formulation approach for poorly-water-soluble compounds. (2003) — 1,301 citations